Patterns of person-centred communications in public HIV clinics: a latent class analysis using the Roter interaction analysis system.

HIV Roter interaction analysis system (RIAS) latent class analysis patient experience patient−provider communication retention in care

Journal

Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566

Informations de publication

Date de publication:
07 2023
Historique:
received: 27 10 2022
accepted: 15 05 2023
medline: 7 7 2023
pubmed: 6 7 2023
entrez: 6 7 2023
Statut: ppublish

Résumé

Poor client-provider communication is a critical barrier to long-term retention in care among people living with HIV. However, standardized assessments of this key metric are limited in Africa. We used the Roter Interaction Analysis System (RIAS) to quantitatively characterize patterns of person-centred communication (PCC) behaviours in Zambia. We enrolled pairs of people living with HIV making routine HIV follow-up visit and their providers at 24 Ministry of Health-facilities supported by the Centre for Infectious Disease Research in Zambia in Lusaka province between August 2019 and November 2021. Client-provider encounters were audio-recorded and coded using RIAS by trained research staff. We performed latent class analysis to identify interactions with distinctive patterns of provider PCC behaviours (i.e. rapport building, person-centred counselling, PCC micropractices [e.g. brief empathy statements], assessing barriers to care, shared decision-making and leveraging discretionary power) and compared their distribution across client, provider, interaction and facility characteristics. We enrolled 478 people living with HIV and 139 providers (14% nurses, 73.6% clinical officers, 12.3% were medical officers). We identified four distinct profiles: (1) "Medically Oriented Interaction, Minimal PCC Behaviours" (47.6% of interactions) was characterized by medical discussion, minimal psychosocial/non-medical talk and low use of PCC behaviours; (2) "Balanced Medical/Non-medical Interaction, Low PCC Behaviours" (21.0%) was characterized by medical and non-medical discussion but limited use of other PCC behaviours; (3) "Medically Oriented Interaction, Good PCC Behaviours" (23.9%) was characterized by medically oriented discussion, more information-giving and increased use of PCC behaviours; and (4) "Highly person-centred Interaction" (7.5%) was characterized by both balanced medical/non-medical focus and the highest use of PCC behaviours. Nurse interactions were more likely to be characterized by more PCC behaviours (i.e. Class 3 or 4) (44.8%), followed by medical officers (33.9%) and clinical officers (27.3%) (p = 0.031). Longer interactions were also more likely to integrate more PCC behaviours (p < 0.001). PCC behaviours are relatively uncommon in HIV care in Zambia, and often limited to brief rapport-building statements and PCC micropractices. Strengthening PCC, such as shared decision-making and leveraging discretionary power to better accommodate client needs and preferences, may be an important strategy for improving the quality in HIV treatment programmes.

Identifiants

pubmed: 37408449
doi: 10.1002/jia2.26119
pmc: PMC10323315
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e26119

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR002346
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI134413
Pays : United States

Informations de copyright

© 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.

Références

Patient Educ Couns. 2002 Apr;46(4):243-51
pubmed: 11932123
Patient Educ Couns. 2013 Nov;93(2):312-8
pubmed: 23906648
Patient Educ Couns. 2018 Jun;101(6):1075-1081
pubmed: 29329726
Health Policy Plan. 2014 Dec;29 Suppl 3:iii51-69
pubmed: 25435536
Nat Commun. 2021 Jul 16;12(1):4450
pubmed: 34272399
SSM Popul Health. 2017 Dec;3:539-548
pubmed: 29270460
JAMA. 1997 Jan 22-29;277(4):350-6
pubmed: 9002500
BMJ Glob Health. 2022 Jan;7(1):
pubmed: 35078810
N Engl J Med. 2021 Jan 14;384(2):101-103
pubmed: 33502832
J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218823285
pubmed: 30798666
J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):62-72
pubmed: 33105396
PLoS One. 2019 Jan 10;14(1):e0210408
pubmed: 30629648
Sex Transm Infect. 2017 Jul;93(Suppl 3):
pubmed: 28736392
J Gen Intern Med. 2006 Jun;21(6):661-5
pubmed: 16808754
Am J Med Genet C Semin Med Genet. 2006 Nov 15;142C(4):209-20
pubmed: 16941666
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):147-152
pubmed: 33136818
Pan Afr Med J. 2020 Sep 25;37:88
pubmed: 33244351
Hum Resour Health. 2013 Jul 17;11:32
pubmed: 23866692
AIDS Res Treat. 2013;2013:706191
pubmed: 23476754
Cochrane Database Syst Rev. 2001;(4):CD003267
pubmed: 11687181
Trop Med Int Health. 2015 Apr;20(4):430-47
pubmed: 25583302
BMC Public Health. 2022 Nov 30;22(1):2238
pubmed: 36451158
J Health Commun. 2018;23(6):591-596
pubmed: 29979930
PLoS Med. 2018 Aug 13;15(8):e1002636
pubmed: 30102693
Front Health Serv. 2022 Sep 14;2:918874
pubmed: 36925865
BMJ Glob Health. 2018 Oct 25;3(5):e001007
pubmed: 30483408
AIDS Behav. 2020 Apr;24(4):1151-1160
pubmed: 31673912
Curr HIV/AIDS Rep. 2019 Aug;16(4):324-334
pubmed: 31230342
Clin Infect Dis. 2021 Oct 5;73(7):e2294-e2302
pubmed: 33011803
BMJ Open. 2018 Jan 23;8(1):e019224
pubmed: 29362266
PLoS One. 2018 Mar 14;13(3):e0193641
pubmed: 29538443
Struct Equ Modeling. 2015 Jan;22(1):1-11
pubmed: 25614730
Health Care Anal. 2015 Sep;23(3):272-87
pubmed: 23807735
Z Evid Fortbild Qual Gesundhwes. 2022 Jun;171:6-10
pubmed: 35610132
Niger J Clin Pract. 2014 Mar-Apr;17(2):241-7
pubmed: 24553039
J Gen Intern Med. 2003 May;18(5):335-42
pubmed: 12795731
PLoS Med. 2013;10(1):e1001369; discussion e1001369
pubmed: 23341753
Patient Educ Couns. 2015 Sep;98(9):1078-83
pubmed: 26021185
J Health Commun. 2018;23(2):129-143
pubmed: 29281593
BMC Health Serv Res. 2008 Oct 09;8:210
pubmed: 18844998
AIDS Care. 2016;28(5):620-7
pubmed: 26695005
PLoS One. 2014 Sep 17;9(9):e107828
pubmed: 25229640
AIDS Patient Care STDS. 2014 Sep;28(9):483-8
pubmed: 25093247
Int J Qual Health Care. 2014 Apr;26(2):190-7
pubmed: 24519123
Trop Med Int Health. 2010 Sep;15(9):1099-108
pubmed: 20545920
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):362-6
pubmed: 23591637
J Int Assoc Provid AIDS Care. 2021 Jan-Dec;20:23259582211054935
pubmed: 34787014
PLoS Med. 2019 Dec 31;16(12):e1003020
pubmed: 31891581
J Acquir Immune Defic Syndr. 2019 Dec;82 Suppl 3:S230-S243
pubmed: 31764259

Auteurs

Njekwa Mukamba (N)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Chanda Mwamba (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Salil Redkar (S)

University of Washington St. Louis, St. Louis, Missouri, USA.

Marksman Foloko (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Kasapo Lumbo (K)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Herbert Nyirenda (H)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Debra L Roter (DL)

Department of Health, Behaviour and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Musunge Mulabe (M)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Anjali Sharma (A)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Sandra Simbeza (S)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Kombatende Sikombe (K)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Laura K Beres (LK)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Jake M Pry (JM)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
California Department of Public Health, Richmond, California, USA.

Katerina Christopoulos (K)

Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Charles B Holmes (CB)

Centre for Global Health and Quality, Georgetown University Medical Center, Washington, DC, USA.
Department of Medicine, University of California San Francisco, San Francisco, California, USA.

Elvin H Geng (EH)

University of Washington St. Louis, St. Louis, Missouri, USA.

Izukanji Sikazwe (I)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Carolyn Bolton-Moore (C)

Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.

Aaloke Mody (A)

University of Washington St. Louis, St. Louis, Missouri, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH